DRIFT's 24-hour price fluctuation reaches 56.2%: price rebounded from a low of $0.0402 to a high of $0.0628, currently at $0.0586, due to low liquidity technical volatility.
Bitget Pulse2026/04/16 12:58Volatility Brief
In the past 24 hours, DRIFT has shown dramatic price movements, first dipping to $0.0402, then surging to $0.0628, and is currently trading at $0.0586, with a price fluctuation range as high as 56.2%. According to CoinGecko, trading volume during the same period was approximately $9.24 million, with a 24-hour range between $0.04059 and $0.04775 (with higher peaks on some platforms), and a total market cap of $26.25 million.
Brief Analysis of the Cause of Unusual Movements
• No major events such as official announcements, mainstream news, or significant on-chain monitoring reports (e.g., whale large transfers or protocol upgrades) were observed in the past 24 hours.
• DefiLlama shows the protocol TVL has remained stable at $243 million, with 24-hour fees of $73,750. However, perpetual contract trading volume is 0 (possibly impacted by suspended deposits), with no abnormal net inflow or outflow of funds.
• The unusual movement may originate from a technical rebound in a low-liquidity market, as trading signals on the X platform indicate a short-term upward trend (e.g., RSI 63, ADX 13 showing healthy upward momentum).
Market View and Outlook
The mainstream community sentiment ranges from neutral to cautious. Traders on X (such as Finora AI) generally regard the $0.04 level as support and are optimistic about a rally above $0.05 after a shallow correction, but emphasize the need to confirm reversal signals to avoid chasing highs. Analysts predict a moderate short-term rise toward around $0.041. Risk warning: Protocol deposits are still suspended, TVL is recovering slowly, beware of further volatility.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
RNA therapy company Adarx Pharmaceuticals (ADRX.US) plans to raise up to $372 million in a U.S. IPO; pharmaceutical giant AbbVie (ABBV.US) has agreed to invest up to $100 million
RNA therapy company Adarx Pharmaceuticals, which is in the late stage of clinical development, plans to raise up to $371.9 million through its initial public offering (IPO) in the United States.
Ledger CTO urges crypto holders to update iPhones after DarkSword exploit revealed
Crypto ICOs Left in Limbo After CLARITY Act Fails in Senate